Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1977 1
1978 1
1980 2
1981 7
1984 1
1985 1
1986 1
1989 2
1990 3
1991 2
1992 6
1993 3
1994 3
1995 3
1996 6
1997 5
1998 8
1999 7
2000 13
2001 11
2002 12
2003 26
2004 35
2005 28
2006 27
2007 25
2008 27
2009 28
2010 43
2011 32
2012 21
2013 27
2014 19
2015 18
2016 22
2017 17
2018 19
2019 18
2020 16
2021 11
2022 10
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 15201783

514 results

Results by year

Filters applied: . Clear all
Page 1
New therapeutic options for refractory neurogenic detrusor overactivity.
Giannantoni A, Mearini E, Di Stasi SM, Costantini E, Zucchi A, Mearini L, Fornetti P, Del Zingaro M, Navarra P, Porena M. Giannantoni A, et al. Minerva Urol Nefrol. 2004 Mar;56(1):79-87. Minerva Urol Nefrol. 2004. PMID: 15195033 Free article. Clinical Trial.
Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study.
Schurch B, de Sèze M, Denys P, Chartier-Kastler E, Haab F, Everaert K, Plante P, Perrouin-Verbe B, Kumar C, Fraczek S, Brin MF; Botox Detrusor Hyperreflexia Study Team. Schurch B, et al. J Urol. 2005 Jul;174(1):196-200. doi: 10.1097/01.ju.0000162035.73977.1c. J Urol. 2005. PMID: 15947626 Clinical Trial.
514 results